Hims & Hers Health, Inc. (NYSE: HIMS ) has hit a bumpy ride over the last year, with the stock stuck in a range from $40 to $70. The online health and wellness platform has faced a lot of questions regarding compounding GLP-1s, with the latestAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in HIMS over the next 7 ...

公司股价表现与市场关注点 - Hims & Hers Health公司股票在过去一年中表现震荡，价格在40美元至70美元区间内波动[1] - 这家在线健康与保健平台因其复合GLP-1药物相关问题而面临大量市场质疑[1] 分析师持仓披露 - 文章作者声明在撰写时未持有所提及公司的任何股票、期权或类似衍生品头寸[1] - 但作者可能在接下来的72小时内通过购买股票或看涨期权等方式，在HIMS公司建立多头头寸[1] 文章性质与作者声明 - 文章内容代表作者个人观点[1] - 作者除从Seeking Alpha平台获得报酬外，未因撰写此文获得其他补偿[1] - 作者与文中提及的任何股票所属公司均无业务关系[1]